Legacy Wealth Managment, Llc/Id Neurocrine Biosciences Inc Transaction History
Legacy Wealth Managment, Llc/Id
- $142 Million
- Q3 2024
A detailed history of Legacy Wealth Managment, Llc/Id transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Legacy Wealth Managment, Llc/Id holds 14 shares of NBIX stock, worth $1,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$1,913% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
627Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.37 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$704 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$352 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$255 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...